Xiaoyu Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaoyu Xie has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Congqing Jiang
Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
17 shared publications - Xianghai Ren
Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
17 shared publications - Jianhong Zhao
Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
15 shared publications - Baoxiang Chen
Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
14 shared publications - Haisheng Yu
Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Hubei Key Laboratory of Tumor Biological Behavior, Hubei Provincial Clinical Research Center for Cancer, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China
14 shared publications - Jinfang Zhang
Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Hubei Key Laboratory of Tumor Biological Behavior, Hubei Provincial Clinical Research Center for Cancer, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China
14 shared publications
Latest Publications
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S9 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
AMPK-mediated ChREBP phosphorylation inhibits the expression of chemokine and choline metabolism genes or proteins.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
AMPK-mediated ChREBP phosphorylation inhibits the expression of chemokine and choline metabolism genes or proteins.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Hyperexpression of ChREBP is associated with a poor prognosis and “immune deserts” phenotype in CRC.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Hyperexpression of ChREBP is associated with a poor prognosis and “immune deserts” phenotype in CRC.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
ChREBP promotes chemokine production and recruits TAMs to induce tumor immune evasion.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
ChREBP promotes chemokine production and recruits TAMs to induce tumor immune evasion.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Choline induced macrophages to acquire an immunostimulatory phenotype.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Choline induced macrophages to acquire an immunostimulatory phenotype.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
The differential metabolites identified by LC-MS from shChrebp or shNC MC38 tumors.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
The differential metabolites identified by LC-MS from shChrebp or shNC MC38 tumors.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S10 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
AMPK activation enhances the efficacy of anti-PD-L1 therapy by increasing phosphorylation of ChREBP.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
AMPK activation enhances the efficacy of anti-PD-L1 therapy by increasing phosphorylation of ChREBP.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Gating and sorting strategies.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Gating and sorting strategies.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
ChREBP interacts with SP1 to promote the expression of chemokine and choline metabolism genes.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
ChREBP interacts with SP1 to promote the expression of chemokine and choline metabolism genes.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
ChREBP interacts with SP1 and promotes SP1 binding to chemokine and choline metabolism gene promoters.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
ChREBP interacts with SP1 and promotes SP1 binding to chemokine and choline metabolism gene promoters.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Data from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Tumor metabolic reprogramming has been recognized as a critical determinant in tumor development and cancer immunotherapy response. Aberrant choline metabolism is emerging as a defining hallmark of cancer. In this study, we found that carbohydrate-responsive element-binding protein (ChREBP)–mediated choline deprivation induced tumor-associated macrophage (TAM) reprogramming and maintained an immunosuppressive tumor microenvironment. Mechanistically, ChREBP interacted with SP1 to increase the expression of immunosuppressive chemokines CCL2 and CCL7 and choline transporter SLC44A1. As such, high CCL2 and CCL7 expression promoted recruitment of TAMs. Tumor cells with high SLC44A1 levels competed with M1-like TAMs for choline, inhibiting cGAS/STING signaling and promoting the repolarization of M1-like to M2-like macrophages. Clinically, ChREBP–SP1–choline metabolism axis expression was associated with poor clinical outcome in colorectal cancer. Thus, the study identified the interplay between tumors and TAMs via choline competition as a previously unknown immune evasion mechanism in the tumor microenvironment and proposes ChREBP as a potential immunotherapeutic target in cancer.Significance:ChREBP induces a choline-deprived tumor microenvironment and promotes chemokine secretion to facilitate immune evasion, suggesting targeting ChREBP as a therapeutic approach to improve the efficacy of immunotherapy.
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion
Tumor metabolic reprogramming has been recognized as a critical determinant in tumor development and cancer immunotherapy response. Aberrant choline metabolism is emerging as a defining hallmark of cancer. In this study, we found that carbohydrate-responsive element-binding protein (ChREBP)–mediated choline deprivation induced tumor-associated macrophage (TAM) reprogramming and maintained an immunosuppressive tumor microenvironment. Mechanistically, ChREBP interacted with SP1 to increase the expression of immunosuppressive chemokines CCL2 and CCL7 and choline transporter SLC44A1. As such, high CCL2 and CCL7 expression promoted recruitment of TAMs. Tumor cells with high SLC44A1 levels competed with M1-like TAMs for choline, inhibiting cGAS/STING signaling and promoting the repolarization of M1-like to M2-like macrophages. Clinically, ChREBP–SP1–choline metabolism axis expression was associated with poor clinical outcome in colorectal cancer. Thus, the study identified the interplay between tumors and TAMs via choline competition as a previously unknown immune evasion mechanism in the tumor microenvironment and proposes ChREBP as a potential immunotherapeutic target in cancer.Significance:ChREBP induces a choline-deprived tumor microenvironment and promotes chemokine secretion to facilitate immune evasion, suggesting targeting ChREBP as a therapeutic approach to improve the efficacy of immunotherapy.